Topic Listing for La Jolla Pharmaceutical Company

Aggregated Option Exercises Last Year-end Values Amendment 1995 Employee Stock Purchase Plan
Amendments Articles Incorporation Bylaws Change Annual Meeting Proposals
Anti-takeover Devices Prevent Changes Management Availability Additional Information
Award Types Because Number Companies Compete Greater Resources Face Rapid
Beneficial Ownership Reporting Compliance Blood Test Measure Binding Affinity Riquent Not Been
Board Committees Meetings Related Matters Board Directors
Class Class Currently Serving Until 2007 Annual Meeting
Class Currently Serving Until 2008 Annual Meeting Class Currently Serving Until 2009 Annual Meeting
Class Currently Serving Until 2010 Annual Meeting Code Conduct
Committees Board Directors Common Stock Price Volatile Decline Even Business Doing
Common Stock Subject Plan Communications Board Directors
Compensation Committee Interlocks Insider Participation Compensation Committee Report
Compensation Discussion Analysis Continuing Directors
Corporate Governance Guidelines Corporate Governance Guidelines Committee Charters
Corporate Transactions Costs Associated Exit Disposal Activities
Current Future Clinical Trials Delayed Halted Currently Devoting Nearly Resources Development Approval Riquent Accordingly
Delivery Documents Stockholders Sharing Same Address Departure Directors Certain Officers Election Appointment Compensatory
Departure Directors Principal Officers Election Appointment Director Attendance Annual Meetings
Director Compensation Director Compensation Table 2006
Director Compensation Table 2007 Director Independence
Director Nominations Discussions Fda Not Result Obtaining Accelerated Approval Riquent
Dividend Equivalents Drugs Not Achieve Market Acceptance
Employee Stock Purchase Plan Employment Agreements
Entry Material Definitive Agreement Equity Compensation Plan Information
Even Receive Regulatory Approval Product Candidates Subject Ongoing Executive Officers Registrant
Exercise Price Face Environmental Liabilities Related Certain Hazardous Materials Used
Failure Achieve Maintain Effective Internal Controls Accordance 404 Federal Income Tax Consequences
Financial Statements Exhibits Form Option Grant
Freedom Operate Business Profit Fully Sales Products Limited Future Sales Stock Stockholders Negatively Affect Market Price
Future Stock Removed Listing Nasdaq Quotation System Not General
Grants Additional Options Grants Incentive Awards
Grants Initial Options Grants Plan-based Awards Table 2006
Grants Plan-based Awards Table 2007 Held Thursday 2006
Held Thursday 2007 Held Thursday 2008
History Losses Not Become Profitable Incorporation Reference
Independent Registered Public Accounting Firm Independent Registered Public Accounting Firm Fees
Interest Certain Persons Matters Acted Interruption Operation Sole Manufacturing Facility Disrupt Operations
Jolla Pharmaceutical Jolla Pharmaceutical 1995 Employee Stock Purchase Plan
Lack Experience Marketing Products Commercial Sale Lead Independent Director
Limited Manufacturing Capabilities Experience Result Shortages Products Clinical Material Modifications Rights Security Holders
Miscellaneous Need Additional Funds Support Operations
Need Sell Stock Assets Enter Collaborative Agreements Reduce Nominees Director
Not Able Take Advantage Orphan Drug Designation Riquent Not Earn Much Income Hope Due Possible Changes
Not Obtain Subpart Approval Riquent Raise Additional Funds Not Pay Dividends Negatively Affect Price Stock
Obtain Regulatory Approval Riquent Validate Manufacturing Facilities Processes Option Exercises Stock Vested 2006
Option Exercises Stock Vested 2007 Options
Order Complete Ongoing Clinical Trial Riquent Need Additional Order Complete Ongoing Clinical Trial Riquent Need Enroll
Other Events Other Matters Business
Other Provisions Performance Awards
Plan Plan Benefits
Purpose Plan Reasons Proposal
Recent Developments Regulation Disclosure
Regulatory Approvals Obtain Product Candidates Limited Subsequent Issues Related Party Transactions
Report Audit Committee Report Compensation Committee Executive
Required Design Conduct Additional Trials Research Development Operations Depend Part Key Employees Losing
Restraint Restricted Stock
Results Clinical Trials Not Sufficient Obtain Approval Market Results Operations Financial Condition
Retaining Current Personnel Recruiting Additional Critical Success Review Approval Related Party Transactions
Riquent Other Potential Products Clinical Trials Well Sale Risk Factors
Role Executives Compensation Decisions Rule 14a-101
Signatures Size Market Potential Products Uncertain
Stock Appreciation Rights Stock Payments
Stock Performance Graph Stockholder Proposals
Success Developing Marketing Drug Candidates Depends Significantly Ability Summary 2004 Plan
Suppliers Not Able Provide Sufficient Quantities Materials Need Tax Accounting Implications
Technology Underlying Products Uncertain Unproven Term Options Effect Termination
Termination Material Definitive Agreement Top Form
Unregistered Sales Equity Securities Vesting Exercise
Vote Required Recommendation Board Vote Required Recommendation Board Directors
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki